Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection. J Pediatr 1998 Aug;133(2):279-81 PMID: 9709722

Pubmed ID

9709722

Abstract

A 14-year-old girl with perinatally acquired human immunodeficiency virus infection had fatal intravascular hemolysis after intravenous administration of ceftriaxone. Laboratory studies confirmed the presence of an antibody against ceftriaxone in the serum and on the patient's red blood cells. No evidence of sepsis, glucose-6-phosphate dehydrogenase deficiency or anaphylaxis was found.

Author List

Moallem HJ, Garratty G, Wakeham M, Dial S, Oligario A, Gondi A, Rao SP, Fikrig S

Author

Martin K. Wakeham MD Associate Professor in the Pediatrics department at Medical College of Wisconsin




Scopus

2-s2.0-0031928314   34 Citations

MESH terms used to index this publication - Major topics in bold

AIDS-Related Opportunistic Infections
Adolescent
Anemia, Hemolytic
Antibodies
Ceftriaxone
Cephalosporins
Fatal Outcome
Female
HIV Infections
Hemolysis
Humans
jenkins-FCD Prod-321 98992d628744e349846c2f62ac68f241d7e1ea70